| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Carroll J Martin is a Director at TherapeuticsMD, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $555K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 | ESPR Esperion Therapeutics, Inc. | Director | Buy | 31,500 | $1.55 | $48,830.58 | +171.1% | +6.7% | +47.0% | |
| Jun 2, 2022 | ESPR Esperion Therapeutics, Inc. | Director | Buy | 5,000 | $5.64 | $28,179.50 | New | +32.7% | -75.8% | |
| May 13, 2016 | RCKT Rocket Pharmaceuticals, Inc. | Director | Buy | 10,000 | $9.03 | $90,294.00 | New | - | - | |
| May 8, 2015 | TXMD Therapeuticsmd, Inc. | Director | Buy | 10,000 | $6.11 | $61,100.00 | New | - | - |